Merck: Getting Less Attractive


  • Merck’s underlying progress is solid.
  • MRK has rallied a lot over the last year.
  • This has made its shares more expensive and less attractive.

Merck & Co. headquarters in Silicon Valley

Sundry Photography

Article Thesis

Merck & Co., Inc. (NYSE:MRK) is one of the largest pharma companies in the world. Thanks to a strong portfolio with huge drugs such as Keytruda, Merck continues to deliver solid results. Its shares have risen quite

MERCK profit beat

Seeking Alpha

Merck pipeline


Data by YCharts

Data by YCharts

Disclosure: I/we have a beneficial long position in the shares of MRK either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Is This an Income Stream Which Induces Fear?

image.pngThe primary goal of the Cash Flow Kingdom Income Portfolio is to produce an overall yield in the 7% – 10% range. We accomplish this by combining several different income streams to form an attractive, steady portfolio payout. The portfolio’s price can fluctuate, but the income stream remains consistent. Start your free two-week trial today!

Leave a Reply

Your email address will not be published. Required fields are marked *